SOCMA’s Bulk Pharmaceuticals Task Force Develops API Quality Agreement for Custom Manufacturers

FOR IMMEDIATE RELEASE
July 15, 2010

Media Contact:
Christine Sanchez
Manager, Public Relations & Media            
(202) 721-4182
sanchezc@socma.com
 

Washington, DC –  Just two months after unveiling a standardized quality drug agreement for general manufacturers of active pharmaceutical ingredients (API), SOCMA’s Bulk Pharmaceuticals Task Force (BPTF) today announced it has developed a second template for Custom Manufacturers Organizations (CMOs) and their customers.

The CMO template was designed to provide guidance for drafting agreements relating to the custom manufacture and release of APIs regulated by the Food and Drug Administration (FDA). Similar to the general template, the CMO version is based on the collective experience of industry members and is meant to fulfill regulatory requirements in a simplified manner.

BPTF Chairman Brant Zell of Cherokee Pharmaceuticals LLC says "CMOs are getting flooded with customers requesting quality agreements, and that in many cases customers have different and conflicting agreements which may not be practical or regulatory in nature."

“With today’s supply chain issues and the potential for misunderstandings in a global environment, a quality agreement is the best way to ensure compliance and meet FDA’s expectations and filing requirements,” explained Zell, saying that there is a big advantage for suppliers to keep the same quality and regulatory standards for each customer.

The CMO template, which can serve as a legal binding document, takes into account the main differences in custom manufacturing versus routine API manufacturing. Since each project may have different customers and may only be a few batches, using the standardize template is essential.  However, the template does include some flexibility to meet individual drug customers’ needs.  

BPTF is an industry trade organization for US manufacturers of active pharmaceutical ingredients, their intermediates and excipients.  Created in 2002 as an affiliate organization of SOCMA, its primary objective is to seek clarification of current regulatory requirements and to interact with governmental agencies on emerging issues that may impact SOCMA members.

For more information on this, or any other topic relating to current good manufacturing practices of APIs, please visit: www.socma.com/bptf.

####

About SOCMA
SOCMA is the only U.S. based trade association serving the batch, custom and specialty chemical industry. Since 1921, we have represented a diverse membership of small, medium and large chemical companies, making us the leading authority on this sector. SOCMA has a global membership of nearly 300 companies. In the US, members employ more than 100,000 workers across the country and produce 50,000 products valued at $60 billion annually. For more information on our services and products, please visit www.socma.com.

ChemStewards® is SOCMA’s flagship environmental, health, safety and security (EHS&S) continuous performance improvement program.  ChemStewards was created from industry’s commitment to reducing our environmental footprint.  Industry created ChemStewards to meet the unique needs of the batch, custom, and specialty chemical industry. As a mandatory requirement for SOCMA members engaged in the manufacturing or handling of chemicals, ChemStewards is helping participants reach for superior EHS&S performance.  To learn more visit www.chemstewards.com.